A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer
Chemotherapy often induces severe neutropenia due to the myelosuppressive effect. While predictive pharmacokinetic (PK)/pharmacodynamic (PD) models of absolute neutrophil count (ANC) after anticancer drug administrations have been developed, their deployments to routine clinics have been limited due...
Saved in:
Main Authors: | Kyemyung Park (Author), Yukyung Kim (Author), Mijeong Son (Author), Dongwoo Chae (Author), Kyungsoo Park (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predicting the longitudinal changes of levodopa dose requirements in Parkinson's disease using item response theory assessment of real‐world Unified Parkinson's Disease Rating Scale
by: Dongwoo Chae, et al.
Published: (2021) -
Ginsenoside Rg3 for Chemotherapy-Induced Myelosuppression: A Meta-Analysis and Systematic Review
by: Linlin Pan, et al.
Published: (2020) -
Carbohydrates and ginsenosides in shenmai injection jointly improve hematopoietic function during chemotherapy-induced myelosuppression in mice
by: Shiyu Zhang, et al.
Published: (2022) -
A Case of Azathioprine Induced Severe Myelosuppression and Alopecia Totalis in IgA Nephropathy
by: Jae Choon Kim, et al.
Published: (2017) -
Pharmacometabolomic prediction of individual differences of gastrointestinal toxicity complicating myelosuppression in rats induced by irinotecan
by: Yiqiao Gao, et al.
Published: (2019)